The Hesitation That Impacts Your Speed to Therapy
Most manufacturers don't switch hub vendors because of one bad month. They switch because a pattern of small failures builds up until the cost of staying outweighs the cost of leaving. By the time that happens, months of underperformance have already eaten into the commercial value of the program.
The hard part to grasp is that the teams who switch usually see the signs early. However, they absorb them as the cost of doing business instead of treating them as evidence of a structural problem. But can you predict these problems before they appear?
The experts say yes. According to existing perspectives and experience of experts, three patterns tend to show up before a team decides to act:
The first is performance failure. This can look like benefit verification turnaround times beginning to creep past service level agreements. Or maybe denial rates start to spike without a clear explanation. If teams are starting to see signs that lead to patients stalling somewhere in the funnel, but nobody surfaces the problem, the window of intervention is already closing.
The second is a visibility gap. When reporting arrives monthly but is solely retrospective, teams have no way to see what's happening in real time. So, by the time an issue reaches a dashboard, the moment to act on it has passed.
The third is strategic misalignment. If your team chose a partner, that vendor was likely the best fit at launch, but maybe the program has grown more complex since then or volume has changed. Maybe technology hasn't kept pace with the program growth goals. There are a lot of ways programs can be strategically misaligned, but ultimately, partners who aren’t moving in the same direction at the same pace will encounter tension.
Any one of these on its own is worth watching. All three together are usually the point where a team stops managing the problem and starts asking whether the vendor is still the right one.
The market is moving faster than most hub models
Part of what makes these gaps harder to ignore is that the ground underneath hub programs is shifting on three fronts at once.
Payer policy is changing, CMS prior authorization rules are accelerating electronic PA adoption, and payers are updating criteria fast enough that non-standardized submission pathways are driving denials for programs that haven't kept up. Electronic benefit data is improving, but accuracy gaps remain.
Manufacturers are also managing tighter cost pressure as payer formulary dynamics and gross-to-net economics squeeze specialty programs, which means access performance now carries direct commercial weight.
Why teams hesitate and where to start
Knowing a vendor relationship isn't working isn’t the hard part, but acting is. A hub program isn't a subscription a team can cancel and rebuild in a week. It's woven into prescriber, patient, and payer workflows, and the thought of unwinding that while keeping active patients moving can feel like a reasonable choice to stay.
But the right moment to seriously evaluate a switch is when performance problems keep recurring, when your team is burning calories working around vendor challenges, or when the vendor's response to concerns isn’t as responsive as the work deserves.
If the question of whether your hub still fits sits in the back of your mind, this is a good place to start.
